Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,500 shares at $75.00 ($188K) on 2014-06-09, disclosed to the SEC on 2014-06-11.
Scheduled sale ($188k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |